Duchenne muscular dystrophy Archives - Express Pharma

Peptris Technologies out-licenses AI-discovered drug candidate to Revio Therapeutics

Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData

FDA expands approval of gene therapy for patients with Duchenne Muscular Dystrophy

Pfizer investigational gene therapy for DMD fails in Phase 3 study

Givinostat from Italfarmaco gets FDA rare pediatric disease designation in duchenne muscular dystrophy

US FDA approves Viltepso injection for treatment of Duchenne muscular dystrophy mutation

FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation